F.D.A. Panel Recommends Pfizer Boosters for Those Over 65 or at Risk nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
France recalls its ambassador to the U.S. in protest of Biden's submarine deal with Australia. nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
GoLocalProv | FDA Advisory Panel Votes Against Pfizer Third Shot Boosters for Those Under 65 golocalprov.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from golocalprov.com Daily Mail and Mail on Sunday newspapers.
Moderna on Friday evening became the second developer of a COVID-19 vaccine to be granted an emergency use authorization (EUA) by the FDA, allowing patients to be dosed with the company’s messenger RNA (mRNA)-based mRNA-1273 just a week after the agency granted the first.
The company said the first doses of mRNA-1273 will be injected into patients next week. Like Pfizer and BioNTech’s BNT162b2, which received an EUA on December 11, mRNA-1273 is a two-dose vaccine. But Moderna’s vaccine is indicated for the prevention of COVID-19 in individuals 18 years of age and older, rather than 16 and older as BNT162b2 is indicated.